INMB
INmune Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.31
-0.02 ▼ -1.50%
🌙 3월 13일 7:25 PM ET (한국 3/14 08:25)
$1.35
+0.04 ▲ +3.05%
| Index | RUT | P/E | - | EPS (ttm) | -2.14 | Insider Own | 17.01% | Shs Outstand | 0.03B | Perf Week | -1.5% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 40.69% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -16.56% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.26 | Inst Own | 19.36% | Short Float | 17.26% | Perf Quarter | -41.26% |
| Income | -0.05B | P/S | 696.6 | EPS this Y | 24.88% | Inst Trans | 2.08% | Short Ratio | 9.24 | Perf Half Y | -33.5% |
| Sales | 0.00B | P/B | 1.37 | EPS next 5Y | 22.73% | ROA | -115.83% | Short Interest | 3.81M | Perf YTD | -16.03% |
| Book/sh | 0.95 | P/C | 1.26 | EPS past 3/5Y | -3.91% -23.07% | ROE | -155.77% | 52W High | -88.75% ($11.64) | Perf Year | -83.71% |
| Cash/sh | 1.04 | P/FCF | - | Sales past 3/5Y | -57.39% - | ROIC | -191.87% | 52W Low | 12.93% ($1.16) | Perf 3Y | -81.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 2.01% | Gross Margin | - | Volatility(W/M) | 9.67% 9.74% | Perf 5Y | -91.77% |
| Dividend TTM | - | EV/Sales | 163.6 | Sales Y/Y TTM | 19.05% | Oper. Margin | -69724% | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.17 | EPS Q/Q | 59.37% | Profit Margin | -99774% | RSI (14) | 44.57 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.17 | Sales Q/Q | - | SMA20 | -2% ($1.34) | Beta | 0.83 | Target Price | $7 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 10000000 | SMA50 | -11.47% ($1.48) | Rel Volume | 0.57 | Prev Close | $1.33 |
| Employees | 22 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 24.53% - | SMA200 | -46.98% ($2.47) | Avg Volume(3M) | 0.41M | Price | $1.31 |
| IPO | 2019/2/4 | Option/Short | Yes/Yes | Trades | 1477 | Volume | 236,865 | Change | -1.5% |
뉴스 로딩 중...